Frontotemporal dementia (FTD) has a stronger genetic link than most other forms of dementia. Between a third and a half of all people with FTD have a family history of the disease, and in roughly 10 to 20 percent of cases, a single inherited gene mutation is the direct cause. The remaining cases appear to arise without any clear family connection, meaning the disease is hereditary in some families but not all.
How Often FTD Runs in Families
Doctors divide FTD into two broad categories: familial and sporadic. Familial FTD means multiple people across back-to-back generations on the same side of a family have developed FTD or a related condition, such as a grandparent, a parent, and then an adult child. Sporadic FTD means the person is the first in their family to develop the disease, with no known relatives affected.
The split between these two groups isn’t perfectly clean. Some people with “sporadic” FTD may carry a genetic mutation that simply hasn’t shown up in relatives yet, either because family members died young from other causes or because certain mutations don’t always produce symptoms. Still, the overall pattern is clear: FTD is among the most heritable neurodegenerative diseases, far more so than Alzheimer’s disease in most age groups.
The Three Major Gene Mutations
Three genes account for the vast majority of inherited FTD cases. Together, mutations in these genes explain most familial cases, while at least four other rarer genes make up a small additional fraction.
MAPT codes for a protein that stabilizes the internal scaffolding of brain cells. When this gene is mutated, the scaffolding collapses and neurons die. In Western populations, MAPT mutations account for roughly 3 to 14 percent of familial FTD. These mutations are generally considered fully penetrant, meaning nearly everyone who inherits one will eventually develop symptoms. The oldest reported age of onset in one large study was 82.
GRN provides instructions for making a protein called progranulin, which helps brain cells survive and manage inflammation. Mutations here reduce progranulin levels, leading to progressive brain damage. GRN mutations appear in about 1 to 16 percent of familial cases in Western populations, and their penetrance is age-related. Some carriers develop symptoms relatively early, while others remain healthy into their 80s or even 90s.
C9orf72 involves an abnormal repetition of a short DNA sequence that expands over generations. This is the most recently discovered of the three major genes and accounts for 12 to 29 percent of familial FTD in Western populations. It also overlaps significantly with ALS (motor neuron disease), meaning some carriers develop movement problems rather than, or in addition to, cognitive and behavioral changes.
Rarer Genetic Causes
Beyond the big three, several other genes have been linked to FTD, though they collectively account for less than 5 percent of cases. These include VCP, which was one of the first genes found to overlap between FTD and ALS, and TBK1, now recognized as the fourth most common FTD-associated gene. Others like CHMP2B, FUS, and TARDBP round out the list. Because these mutations are rare, they’re typically only discovered when researchers study families with unusual patterns of neurological disease.
What “50 Percent Risk” Actually Means
Most known genetic causes of FTD follow an autosomal dominant inheritance pattern. In practical terms, this means that if one of your parents carries a causative mutation, you have a 50 percent chance of inheriting it with each pregnancy. It doesn’t matter whether you’re male or female.
Inheriting the mutation, however, is not the same as developing symptoms. For MAPT mutations, the two are nearly equivalent: carriers almost always develop the disease at some point. For GRN mutations, the picture is less certain. Some carriers live well into old age without clear symptoms, though the risk increases with every decade. This variability can make family histories confusing, because a mutation may seem to “skip” a generation when in reality that person simply didn’t live long enough for symptoms to appear, or had mild symptoms that were attributed to normal aging.
Which Subtypes Are More Genetic
FTD presents in several clinical forms, and some are more likely to be inherited than others. The behavioral variant (bvFTD), which causes personality changes, impulsivity, and social disinhibition, has the strongest genetic signal. The language-dominant forms, collectively called primary progressive aphasia (PPA), are less heritable. One study found that only about 30 percent of people with the nonfluent variant, 22 percent with the semantic variant, and 20 percent with the logopenic variant had a family history involving at least one first-degree relative with dementia. If you or a loved one has a language-predominant form of FTD, a genetic cause is possible but less likely than with the behavioral variant.
Genetic Testing and Counseling
If FTD has appeared in multiple members of your family, genetic testing can identify whether a specific mutation is responsible. Testing typically starts with the family member who has been diagnosed, because finding a known mutation in that person makes it possible to test other relatives for the same change. If no mutation is found in the affected person, testing healthy relatives is far less informative.
For people without symptoms who want to know their status, the process is modeled on the protocol used for Huntington’s disease. It involves multiple counseling sessions spread over weeks or months, not a single blood draw. Counselors walk you through what a positive or negative result would mean, how it might affect insurance and employment, and what psychological support is available. The process also addresses the reality that some results are ambiguous: genetic testing sometimes turns up variants of unknown significance, meaning a change in DNA that might or might not cause disease.
Testing is a deeply personal decision. A positive result carries no immediate treatment path, since no therapy currently slows or stops FTD. What it does provide is clarity for family planning, financial planning, and the ability to participate in clinical trials that are increasingly targeting specific genetic forms of the disease. Many people choose not to be tested, and that is an equally reasonable choice.
When There’s No Family History
If no one in your family has had FTD or a similar condition, your risk of developing it is low. The majority of sporadic cases appear to result from a complex mix of genetic susceptibility and environmental or biological factors that researchers don’t yet fully understand. Having a single relative with FTD, particularly one who developed it after age 65, does not necessarily indicate a hereditary pattern. The familial designation generally requires multiple affected individuals across consecutive generations on the same side of the family.